ISRCTN84139732已完成不适用
Effects of aspirin on markers of inflammation and coagulation in subclinical atherosclerosis in type 2 diabetic subjects
eiden University Medical Centre (LUMC) (Netherlands)0 个研究点目标入组 40 人开始时间: 2005年12月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Diabetes mellitus type 2
- •2. Aged greater than 18 years
- •3. HbA1c less than 10%
- •4. High sensitivity C-reactive protein (hsCRP) greater than 1.0 mg/l
排除标准
- •1. History of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, proven manifest coronary artery disease, angina pectoris, heart failure or severe cardiac arrhythmia
- •2. History of cerebrovascular accident, transient ischaemic attack
- •3. History of peripheral vascular disease, ankle/arm index less than 10, history of partial ileal bypass surgery
- •4. Uncontrolled hypertension
- •6. Any bleeding disorder
- •7. History of gastrointestinal tract bleeding
- •8. Severe renal or hepatic dysfunction
- •9. Pregnancy
- •10. Recent participation in other research projects
- •11. Recent blood donation
- •12. Known allergy to salicylic acid
- •13. Use of all non-steroidal anti-inflammatory drugs (NSAID?s)
- •14. Use of any anti-thrombotic medication
- •15. Use of corticosteriods
- •16. Use of HMG-CoA-reductase inhibitors
研究者
相似试验
已完成
不适用
The effects of aspirin on pro-inflammatory response in subjects with diabetes mellitusutritional, Metabolic, Endocrine: DiabetesNutritional, Metabolic, EndocrineDiabetesISRCTN45751416Department of Health (UK)120
进行中（未招募）
不适用
The main aim of this study is to look at the effects of a drug called aspirin at reducing inflammation in the lungsThe intended indication for the product under development is that of acute lung injury.MedDRA version: 14.1Level: PTClassification code 10069351Term: Acute lung injurySystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2012-001589-13-GBBelfast Health and Social Care Trust
已完成
不适用
Effects of aspirin on markers of inflammation and coagulation in subclinical atherosclerosis in type 2 diabetic subjects.Diabetes Mellitus type 2, no cardiovascular disease.NL-OMON23321eiden University Medical Center (LUMC), department of General Internal Medicine40
进行中（未招募）
1 期
Assessment of aspirin for the prevention of colorectal cancerColorectal cancer with a recent confirmed diagnosis (less than 48h)MedDRA version: 20.0Level: PTClassification code 10061451Term: Colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-002101-65-ESÁngel Lanas Arbeloa-Instituto de Investigación Sanitaria Aragón60
已完成
Unknown
Association between aspirin dose and outcomes in patients with acute Kawasaki diseaseJPRN-UMIN000049641Fujita health university10,000